Compare CFND & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFND | FORA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 66.2M |
| IPO Year | 2025 | 2020 |
| Metric | CFND | FORA |
|---|---|---|
| Price | $3.82 | $2.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.8K | 16.6K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.68 | $1.64 |
| 52 Week High | $9.67 | $2.71 |
| Indicator | CFND | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 46.06 |
| Support Level | $3.82 | $2.05 |
| Resistance Level | $4.08 | $2.12 |
| Average True Range (ATR) | 0.16 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 70.00 | 40.00 |
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.